StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MOLI.JK$222.00-0.89%
Fair $222.00+0.0%

MOLI.JK

PT Madusari Murni Indah Tbk

Basic Materials / ChemicalsJakarta

$222.00

-2.00 (-0.89%)

Fairly Valued+0.0%Fair Value $222.00Fund rank 31/100 · Data gapFallback financials|
SA 52/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $87.4B · quality 55.3/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

52/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · MOLI.JKLocal privado en este navegador · PT Madusari Murni Indah Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$604.7B

P/E

6.2x

↓

EV/EBITDA

3.8x

↓

ROE

6.1%

↑

Gross Margin

29.1%

↑

Debt/Equity

0.01

↓
52-Week Range$222
$187$412

TradingView lightweight chart

MOLI.JK price, volumen y niveles de valoración

Último $222.00Periodo -76.1%
Fair value: $222.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-0.4%

FCF CAGR

+76.0%

FCF margin

28.2%

FCF / Net income

5.61x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.50T · net income $75.46B · FCF $422.98B

2022-FY → 2025-FY

Gross margin

29.1%+6.0% pts

Operating margin

10.1%+5.3% pts

Net margin

5.0%+3.6% pts

FCF margin

28.2%+23.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1498.00B$1498.00B$1392.54B$1448.23B$1515.32B
Net Income$75.46B$75.46B$12.95B$83.51B$22.52B
EBITDA$145.14B$145.14B$74.01B$167.15B$91.75B
EPS——4.7530.668.27
Gross Margin29.1%29.1%22.3%25.8%23.0%
Operating Margin10.1%10.1%4.0%7.6%4.9%
Net Margin5.0%5.0%0.9%5.8%1.5%
Balance Sheet
Debt/Equity0.010.010.370.450.48
Current Ratio8.628.62———
Cash Flow
Free Cash Flow$422.98B$422.98B$87.36B$-95.76B$77.64B
Returns
ROE6.1%6.1%1.1%7.2%2.1%
Valuation
P/E6.256.2545.4711.9425.88
EV/EBITDA3.783.7813.128.7011.36
P/B0.490.490.510.860.54
Growth & Yield
Revenue Growth7.6%7.6%-3.8%-4.4%—
EPS Growth——-84.5%270.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +5.7%

Total return

+5.7%

Start / end P/E

n/dx → n/dx

EPS bridge

4.75 → n/d

Residual

+5.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+5.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.